United States Immunomodulator Market: PBM Interchangeable...

a adăugat un sunet Health

2026-11-12 20:09:40 - Translate -

United States Immunomodulator Market: PBM Interchangeable Biosimilar Onboarding and Dual-Indication IL-23/JAK Expansion Drive 7.9% CAGR

The global immunomodulator market is projected to increase from USD 262.6 billion in 2026 to USD 526.3 billion by 2036, registering a compound annual growth rate (CAGR) of 7.2% during the forecast period, according to Future Market Insights (FMI). The market was valued at USD 245.0 billion in 2025, with the projected expansion representing an additional USD 263.7 billion in market revenue...

0 Commentarii 0 Distribuiri 12 Views 0 previzualizare